DreaMed Diabetes offers AI solutions and personalized support for optimized insulin therapy.
DreaMed Diabetes has raised $3.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.
DreaMed Diabetes's investors include Medtronic, eHealth Ventures, Millhouse, The Leona M. and Harry B. Helmsley Charitable Trust.
DreaMed Diabetes is headquartered in Petah Tiqva, Israel.
DreaMed Diabetes offers AI solutions and personalized support for optimized insulin therapy.
DreaMed Diabetes is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DreaMed Diabetes — Funding & Investors." VCBacked, August 19, 2024, https://www.vcbacked.co/company/dreamed-diabetes. Accessed October 31, 2026.
VCBacked. (2024). DreaMed Diabetes — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/dreamed-diabetes
{{cite web |title=DreaMed Diabetes — Funding & Investors |url=https://www.vcbacked.co/company/dreamed-diabetes |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated